Menu Search
Equities

Nanalysis Scientific Corp.

1N1:FRA

Nanalysis Scientific Corp.

Actions
  • Price (EUR)0.368
  • Today's Change-0.018 / -4.66%
  • Shares traded0.00
  • 1 Year change-56.96%
  • Beta--
Data delayed at least 15 minutes, as of Jun 05 2023 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nanalysis Scientific Corp. is a Canada-based company, which develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The Company's NMReady-60 is a full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. It operates through three segments: Nanalysis, RS2D and Corporate. Through its European subsidiary RS2D S.A.S. (RS2D), the Company also manufactures and distributes electronic boards and software are used in NMR and MRI equipment. Its 60 and 100 megahertz (MHz) spectrometers incorporate permanent magnets and require no liquid helium or other cryogens. Its product offerings are based upon its magnet technology, as well as its Cam4 technology. Its devices are used in many industries, such as oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, and law enforcement) as well as government and university research labs.

  • Revenue in CAD (TTM)23.94m
  • Net income in CAD-12.74m
  • Incorporated2017
  • Employees249.00
  • Location
    Nanalysis Scientific Corp.Bay 1, 4600 - 5th Street NECALGARY T2E 7C3CanadaCAN
  • Phone+1 (587) 899-0513
  • Fax+1 (587) 899-0513
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.